3-Methylazetidine-3-carbonitrile hydrochloride

Catalog No.: 
ACZIOT047
CAS No.: 
936850-33-8
Molecular Formula: 
C5H9ClN2
Molecular Weight: 
132.59
3-Methylazetidine-3-carbonitrile hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$215.00In stockIn stock
25g95%$973.00InquiryIn stock
100g95%$3425.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Methylazetidine-3-carbonitrile hydrochloride
IUPAC Name3-methylazetidine-3-carbonitrile hydrochloride
MDL No.MFCD11849039
Molecular FormulaC5H9ClN2
Molecular Weight132.59
SMILESN#CC1(C)CNC1.[H]Cl
InChI KeyDCXJKYVRMRUVTJ-UHFFFAOYSA-N
Synonym936850-33-8 | 3-Methylazetidine-3-carbonitrile hydrochloride | 3-CYANO-3-METHYLAZETIDINE HYDROCHLORIDE | 3-CYANO-3-METHYLAZETIDINE HCL | 3-methylazetidine-3-carbonitrile;hydrochloride | 3-METHYL-3-AZETIDINECARBONITRILE HYDROCHLORIDE | 3-Methylazetidine-3-carbonitrile
CAS No.936850-33-8
PubChem CID57516623

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACZIOT047 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACILTB461 route compound structure diagram
    ACILTB461936850-09-8In Stock
  2. Then
  3. ACZIOT047 route product structure diagram
    ACZIOT047936850-33-8In Stock
Inquiry

2. ACZIOT047 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZIOT047 route product structure diagram
    ACZIOT047936850-33-8In Stock
Inquiry

3. ACZIOT047 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZIOT047 route product structure diagram
    ACZIOT047936850-33-8In Stock
Inquiry

Comments (0)